TECH Relative Valuation
TECH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TECH is overvalued; if below, it's undervalued.
Historical Valuation
Bio-Techne Corp (TECH) is now in the Fair zone, suggesting that its current forward PE ratio of 31.51 is considered Fairly compared with the five-year average of 42.12. The fair price of Bio-Techne Corp (TECH) is between 59.47 to 94.48 according to relative valuation methord.
Relative Value
Fair Zone
59.47-94.48
Current Price：63.82
Fair
31.37
PE
1Y
3Y
5Y
Trailing
Forward
23.31
EV/EBITDA
Bio-Techne Corp. (TECH) has a current EV/EBITDA of 23.31. The 5-year average EV/EBITDA is 29.68. The thresholds are as follows: Strongly Undervalued below 15.58, Undervalued between 15.58 and 22.63, Fairly Valued between 36.73 and 22.63, Overvalued between 36.73 and 43.78, and Strongly Overvalued above 43.78. The current Forward EV/EBITDA of 23.31 falls within the Historic Trend Line -Fairly Valued range.
25.21
EV/EBIT
Bio-Techne Corp. (TECH) has a current EV/EBIT of 25.21. The 5-year average EV/EBIT is 32.04. The thresholds are as follows: Strongly Undervalued below 17.22, Undervalued between 17.22 and 24.63, Fairly Valued between 39.45 and 24.63, Overvalued between 39.45 and 46.86, and Strongly Overvalued above 46.86. The current Forward EV/EBIT of 25.21 falls within the Historic Trend Line -Fairly Valued range.
8.04
PS
Bio-Techne Corp. (TECH) has a current PS of 8.04. The 5-year average PS is 11.14. The thresholds are as follows: Strongly Undervalued below 4.65, Undervalued between 4.65 and 7.90, Fairly Valued between 14.38 and 7.90, Overvalued between 14.38 and 17.62, and Strongly Overvalued above 17.62. The current Forward PS of 8.04 falls within the Historic Trend Line -Fairly Valued range.
23.18
P/OCF
Bio-Techne Corp. (TECH) has a current P/OCF of 23.18. The 5-year average P/OCF is 36.87. The thresholds are as follows: Strongly Undervalued below 16.71, Undervalued between 16.71 and 26.79, Fairly Valued between 46.95 and 26.79, Overvalued between 46.95 and 57.03, and Strongly Overvalued above 57.03. The current Forward P/OCF of 23.18 falls within the Undervalued range.
24.83
P/FCF
Bio-Techne Corp. (TECH) has a current P/FCF of 24.83. The 5-year average P/FCF is 42.14. The thresholds are as follows: Strongly Undervalued below 18.90, Undervalued between 18.90 and 30.52, Fairly Valued between 53.76 and 30.52, Overvalued between 53.76 and 65.39, and Strongly Overvalued above 65.39. The current Forward P/FCF of 24.83 falls within the Undervalued range.
Bio-Techne Corp (TECH) has a current Price-to-Book (P/B) ratio of 5.06. Compared to its 3-year average P/B ratio of 5.56 , the current P/B ratio is approximately -9.00% higher. Relative to its 5-year average P/B ratio of 7.21, the current P/B ratio is about -29.90% higher. Bio-Techne Corp (TECH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.21%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.03% , the current FCF yield is about -100.00% lower.
5.03
P/B
Median3y
5.56
Median5y
7.21
2.25
FCF Yield
Median3y
2.21
Median5y
2.03
Competitors Valuation Multiple
The average P/S ratio for TECH's competitors is , providing a benchmark for relative valuation. Bio-Techne Corp Corp (TECH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -1.00%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TECH decreased by 11.79% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 11.61 to 13.33.
The secondary factor is the Revenue Growth, contributed -1.00%to the performance.
Overall, the performance of TECH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Bio-Techne Corp (TECH) currently overvalued or undervalued?
What is Bio-Techne Corp (TECH) fair value?
How does TECH's valuation metrics compare to the industry average?
What is the current P/B ratio for Bio-Techne Corp (TECH) as of Dec 05 2025?
What is the current FCF Yield for Bio-Techne Corp (TECH) as of Dec 05 2025?
What is the current Forward P/E ratio for Bio-Techne Corp (TECH) as of Dec 05 2025?